Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...

The research team at the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences confirmed the ...

A new study has identified the protein hnRNP A1 as a key player in the production and maintenance of myelin, the fatty sheath ...

Amyotrophic lateral sclerosis (ALS) is a relatively rare but very serious disease of the nervous system. A cure is not yet ...

Monument Therapeutics, a precision-neuroscience company focused on the development of innovative treatments for serious central nervous system disorders (CNS), today announced two key leadership ...

The virus that causes shingles is just one of a number of pathogens that may be linked to brain conditions. Here are some of ...

Farooq Nasar, PhD, Senior Principal Investigator, Research and Development Center, Tonix Pharmaceuticals ...

April is Parkinson’s Awareness Month and, according to the Parkinson's Foundation, nearly 90,000 people in the US are ...

NEO100 has been granted both Orphan Drug Designation and Fast Track Status by the U.S. Food and Drug Administration (FDA), reinforcing its potential as a significant advancement in the treatment of ...